Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06245512

Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood

RECHERCHE DE MARQUEURS DIAGNOSTIQUES ET PRONOSTIQUES DE L'ENDOMETRIOSE DANS LE SANG DES REGLES CHEZ LES FEMMES EN AGE DE PROCREER

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to identify diagnostic and prognostic biomarkers for endometriosis using menstrual blood, an easily accessible yet overlooked biological fluid in women of reproductive age, affected or not by endometriosis The main questions it aims to answer are: * are there relevant differences in the menstrual blood of women affected by endometriosis compared to women without endometriosis? * do some of these differences disappear or lessen when the disease is treated by surgery? Participants will answer questions relevant to endometriosis and provide menstrual blood 1 to 3 times (self-collected with a menstrual cup). A subgroup of participants affected by endometriosis that will undergo surgery for their regular care will provide menstrual blood before and after their surgery. Researchers will compare the menstrual blood of women with and without endometriosis, and before and after surgery to see if they can identify significant differences.

Conditions

Timeline

Start date
2024-07-31
Primary completion
2027-03-30
Completion
2027-03-30
First posted
2024-02-07
Last updated
2026-04-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06245512. Inclusion in this directory is not an endorsement.

Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood (NCT06245512) · Clinical Trials Directory